BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 27784692)

  • 1. A kidney-selective biopolymer for targeted drug delivery.
    Bidwell GL; Mahdi F; Shao Q; Logue OC; Waller JP; Reese C; Chade AR
    Am J Physiol Renal Physiol; 2017 Jan; 312(1):F54-F64. PubMed ID: 27784692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utilizing a Kidney-Targeting Peptide to Improve Renal Deposition of a Pro-Angiogenic Protein Biopolymer.
    Mahdi F; Chade AR; Bidwell GL
    Pharmaceutics; 2019 Oct; 11(10):. PubMed ID: 31635263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Size Modulates Pharmacokinetics, Biodistribution, and Renal Deposition of the Drug Delivery Biopolymer Elastin-like Polypeptide.
    Kuna M; Mahdi F; Chade AR; Bidwell GL
    Sci Rep; 2018 May; 8(1):7923. PubMed ID: 29784932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymer size affects biodistribution and placental accumulation of the drug delivery biopolymer elastin-like polypeptide in a rodent pregnancy model.
    Kuna M; Waller JP; Logue OC; Bidwell GL
    Placenta; 2018 Dec; 72-73():20-27. PubMed ID: 30501877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic biopolymer-delivered vascular endothelial growth factor promotes therapeutic angiogenesis in experimental renovascular disease.
    Chade AR; Williams ML; Guise E; Vincent LJ; Harvey TW; Kuna M; Mahdi F; Bidwell GL
    Kidney Int; 2018 Apr; 93(4):842-854. PubMed ID: 29273331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recovery of Renal Function following Kidney-Specific VEGF Therapy in Experimental Renovascular Disease.
    Engel JE; Williams ML; Williams E; Azar C; Taylor EB; Bidwell GL; Chade AR
    Am J Nephrol; 2020; 51(11):891-902. PubMed ID: 33130676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A dose-escalating toxicology study of the candidate biologic ELP-VEGF.
    Waller JP; Burke SP; Engel J; Chade AR; Bidwell GL
    Sci Rep; 2021 Mar; 11(1):6216. PubMed ID: 33737643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and Purification of Neurotrophin-Elastin-Like Peptide Fusion Proteins for Neural Regeneration.
    Johnson T; Koria P
    BioDrugs; 2016 Apr; 30(2):117-27. PubMed ID: 26820997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multivalent Targeting Based Delivery of Therapeutic Peptide using AP1-ELP Carrier for Effective Cancer Therapy.
    Sarangthem V; Kim Y; Singh TD; Seo BY; Cheon SH; Lee YJ; Lee BH; Park RW
    Theranostics; 2016; 6(12):2235-2249. PubMed ID: 27924160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal Therapeutic Angiogenesis Using a Bioengineered Polymer-Stabilized Vascular Endothelial Growth Factor Construct.
    Chade AR; Tullos NA; Harvey TW; Mahdi F; Bidwell GL
    J Am Soc Nephrol; 2016 Jun; 27(6):1741-52. PubMed ID: 26541349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corneal Penetrating Elastin-Like Polypeptide Carriers.
    George EM; Mahdi F; Logue OC; Robinson GG; Bidwell GL
    J Ocul Pharmacol Ther; 2016 Apr; 32(3):163-71. PubMed ID: 26672799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of cell penetrating peptides fused to elastin-like polypeptide for drug delivery.
    Massodi I; Bidwell GL; Raucher D
    J Control Release; 2005 Nov; 108(2-3):396-408. PubMed ID: 16157413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fusion of fibroblast growth factor 21 to a thermally responsive biopolymer forms an injectable depot with sustained anti-diabetic action.
    Gilroy CA; Roberts S; Chilkoti A
    J Control Release; 2018 May; 277():154-164. PubMed ID: 29551712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An injectable and in situ-gelling biopolymer for sustained drug release following perineural administration.
    Shamji MF; Whitlatch L; Friedman AH; Richardson WJ; Chilkoti A; Setton LA
    Spine (Phila Pa 1976); 2008 Apr; 33(7):748-54. PubMed ID: 18379401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fusions of elastin-like polypeptides to pharmaceutical proteins.
    Hassouneh W; MacEwan SR; Chilkoti A
    Methods Enzymol; 2012; 502():215-37. PubMed ID: 22208987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted Drug Delivery Biopolymers Effectively Inhibit Breast Tumor Growth and Prevent Doxorubicin-Induced Cardiotoxicity.
    Dragojevic S; Ryu JS; Hall ME; Raucher D
    Molecules; 2022 May; 27(11):. PubMed ID: 35684309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thermally targeted delivery of chemotherapeutics and anti-cancer peptides by elastin-like polypeptide.
    Raucher D; Massodi I; Bidwell GL
    Expert Opin Drug Deliv; 2008 Mar; 5(3):353-69. PubMed ID: 18318656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of molecular weight and structural conformation of multivalent-based elastin-like polypeptides on tumor accumulation and tissue biodistribution.
    Sarangthem V; Seo BY; Yi A; Lee YJ; Cheon SH; Kim SK; Singh TD; Lee BH; Park RW
    Nanotheranostics; 2020; 4(2):57-70. PubMed ID: 32190533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cadmium detection by a thermally responsive elastin copolymer with metal-binding functionality.
    Chu HS; Ryum J; Won JI
    Enzyme Microb Technol; 2013 Aug; 53(3):189-93. PubMed ID: 23830461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elastin-like polypeptides: A strategic fusion partner for biologics.
    Yeboah A; Cohen RI; Rabolli C; Yarmush ML; Berthiaume F
    Biotechnol Bioeng; 2016 Aug; 113(8):1617-27. PubMed ID: 27111242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.